Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Dracen Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsDracen Pharmaceuticals, Inc.

Dracen Pharmaceuticals, Inc.

ACTIVE

780 3RD Ave FL 45, New York City, 马里兰州, United Stateswww.dracenpharma.comHolding1–10 employeesEstablished: 2016-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

2

1 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2016

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

2

100.0%

Trial Status Distribution

Active, not recruiting

1

50.0%

Terminated

1

50.0%

Clinical Trials

Trials sponsored by this organization (2)

First-in-human (FIH) study of DRP-104 as single agent and in combination with atezolizumab in patients with advanced solid tumors.

Active, not recruiting

Oct 2020170 participants

Study to Investigate DRP-104 in Adults With Advanced Solid Tumors

Aug 202061 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials2
Approvals
News

Back to Organizations